Characterization of mouse carboxypeptidase N small active subunit gene structure

被引:10
作者
Matthews, KW
Wetsel, RA
机构
[1] Univ Texas, Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA
[2] Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
关键词
D O I
10.4049/jimmunol.166.10.6196
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Carboxypeptidase N (CPN) is a plasma zinc metalloprotease comprised of two small subunits that have enzymatic activity, and two large subunits, which protect the enzyme from degradation. CPN cleaves the carboxyl-terminal amino acids arginine and lysine from biologically active peptides such as complement anaphylatoxins, kinins, and fibrinopeptides. To delineate the murine CPN small subunit coding region, gene structure, and chromosome location, cDNA and genomic clones were isolated, characterized, and used in Northern and fluorescence in situ hybridization analyses. The results from this study demonstrate that the murine CPN small subunit gene is a single copy gene of similar to 29 kb that is transcribed in the liver into a 1793-bp mRNA with an open reading frame of 1371 nucleotides encoding 457 aa. The gene contains nine exons ranging in size from 455 by (exon 1) to 100 by (exon 7), and eight introns ranging in size from 6.2 kb (intron 2) to 1.4 kb (intron 4). All intron/exon junctions follow the normal consensus rule. The mouse CPN small subunit gene localized to chromosomal band 19D2, which is syntenic to human chromosome 10q23-25. Primer extension experiments using mouse liver mRNA indicate one major transcriptional initiation site and three minor sites. Sequence analysis of the 5'-flanking region indicated a TATA-less promoter and numerous transcription factor binding sites, which may confer liver-specific expression of the CPN small subunit gene.
引用
收藏
页码:6196 / 6202
页数:7
相关论文
共 31 条
[1]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[2]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF VASOACTIVE PEPTIDES DERIVED FROM FIBRIN OR FIBRINOGEN DEGRADED BY PLASMIN [J].
BELEW, M ;
GERDIN, B ;
LINDEBERG, G ;
PORATH, J ;
SALDEEN, T ;
WALLIN, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 621 (02) :169-178
[3]   Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B) [J].
Boffa, MB ;
Reid, TS ;
Joo, E ;
Nesheim, ME ;
Koschinsky, ML .
BIOCHEMISTRY, 1999, 38 (20) :6547-6558
[4]   ANAPHYLATOXIN INACTIVATOR OF HUMAN PLASMA - ITS ISOLATION AND CHARACTERIZATION AS A CARBOXYPEPTIDASE [J].
BOKISCH, VA ;
MULLEREB.HJ .
JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) :2427-&
[5]  
CLAUSER E, 1988, J BIOL CHEM, V263, P17837
[6]  
Ember J., 1998, The Human Complement System in Health and Disease, P241
[7]   AN ENZYME IN HUMAN BLOOD PLASMA THAT INACTIVATES BRADYKININ AND KALLIDINS [J].
ERDOS, EG ;
SLOANE, EM .
BIOCHEMICAL PHARMACOLOGY, 1962, 11 (JUL) :585-+
[8]  
ERDOS EG, 1979, HDB EXPT PHARM S, V25, P427
[9]  
GARDELL SJ, 1988, J BIOL CHEM, V263, P17828
[10]   CELL-TYPE SPECIFIC ACTIVITY OF 2 GLUCOCORTICOID RESPONSIVE UNITS OF RAT TYROSINE AMINOTRANSFERASE GENE IS ASSOCIATED WITH MULTIPLE BINDING-SITES FOR C/EBP AND A NOVEL LIVER-SPECIFIC NUCLEAR FACTOR [J].
GRANGE, T ;
ROUX, J ;
RIGAUD, G ;
PICTET, R .
NUCLEIC ACIDS RESEARCH, 1991, 19 (01) :131-139